VN Research & Consulting
 Like us on facebook  Follow us on twitter  Follow us on LinkedIn  IndiaNotes on Google Plus  IndiaNotes on Pinterest  IndiaNotes on Stumbleupon  Subscribe to our feeds


Stocks  A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Go
Feedback
You are here: IndiaNotes

Filter search : Quote Research All


Reports for search string : Sales

H.G. Infra IPO: An Exciting Road Ahead
HGI has an impressive last 5 years performance where it has emerged as a rising star. Good track record, robust financial performance, sectoral tailwinds and an experienced management team makes this ...
Punit Jain, 24 Feb 2018
Pokarna Q3FY18: Earnings to bottom out in FY18; retain LONG on attractive valuations
Pokarna’s (POKR) 3QFY18 consolidated revenue/EBITDA declined 1%/8% yoy to Rs 879mn/Rs 299mn, coming in lower than EE due to a change in the quartz product mix, higher input prices in quartz and INR ap...
Equirus Securities, 23 Feb 2018
S P Apparels Q3 Results: Growth to return from FY19; maintain Long
S.P. Apparels’ (SPAL) 3QFY18 revenues grew 11% yoy to Rs 1.6bn, 3% above EE, largely due to strong retail revenue growth, even as garment revenues saw flattish growth yoy.
Equirus Securities, 23 Feb 2018
HG Infra Engineering IPO: Subscribe the issue from a long term perspective
Over the last four years (FY13-17), the company has demonstrated good execution skills with revenues growing at 34% CAGR, one of the highest in the listed space. The company is now entering the big le...
Nirmal Bang, 23 Feb 2018
Lumax Industries: Revenue in Q3FY18 surged by 25.5%; Accumulate
Revenue in Q3FY18 surged by 25.5% on account of expansion in volume (15% volume growth y-o-y). Operating margins expanded by 26 bps y-o-y by virtue of optimization of overheads due to increased sales ...
CD Equisearch Pvt Ltd, 23 Feb 2018
Hexaware Technologies Q4CY17: An investment idea for medium to long-term
At the current market price of Rs. 345.30, the stock P/E ratio is at 17.89 x CY18E and 15.91 X CY19E respectively. Net Sales and PAT of the company are expected to grow at a CAGR of 12% and 13% over 2...
Firstcall India Equity, 23 Feb 2018
Apcotex Industries: Net profit jumps to Rs.132.94 mn in Q3FY18; Overweight
The company’s net profit jumps to Rs. 132.94 million from Rs. 50.23 million in the corresponding quarter ending of previous year. Net Sales & PAT of the company are expected to grow at a CAGR of 15% a...
Firstcall India Equity, 23 Feb 2018
The West Coast Paper Mills Q3FY18: Buy for an upside of 60% in 18 months
With the introduction of FY20E numbers, we have re-rated and valued the stock on the basis of EV/EBIDTA of 6.0x (earlier 4.5x) of FY20E EBIDTA and recommend a “Buy” with a target pric...
SKP Research, 22 Feb 2018
Solar Industries Q3FY18: Order book stands at Rs.13060 mn ; Overweight
The company current order book stands at Rs. 13060 mn including defense order book of 1610 mn. With the government’s increased focus on mining, infrastructure, housing, defense and international busin...
Firstcall India Equity, 22 Feb 2018
Visaka Industries Q3FY18: Net profit jumps 141.87%; Overweight
During Q3 FY18, the company’s net profit jumps to Rs. 142.62 mn as compared to Rs. 58.97 mn in the corresponding quarter ending of previous year, up by 141.87%. Operating Profit & PAT of the company a...
Firstcall India Equity, 22 Feb 2018
Crompton Greaves Consumer Electricals: Enough headroom for growth in core categories
We met the management of Crompton Greaves Consumer Electrical (Crompton) and came back convinced about the medium/long term opportunities for growth and management’s strategy/focus to capitalize on th...
Prabhudas Lilladher, 21 Feb 2018
Ambuja Cements 4QCY17 Results: Healthy performance on all counts; maintain Buy
Ambuja Cements (ACL) has reported a better-than-estimated operating performance in 4QCY17, mainly owing to higher-than-expected volume growth and better operational efficiencies.
Reliance Securities, 21 Feb 2018
Escorts Q3FY18: Net profit grows a whopping 305%; Overweight
During the quarter, net profit increased by 305.00% to Rs. 919.77 mn from Rs. 227.10 mn in the corresponding quarter ending of previous year. Net Sales and PAT of the company are expected to grow at a...
Firstcall India Equity, 21 Feb 2018
Avanti Feeds Q3FY18: An investment idea for medium to long-term
At the current market price of Rs. 2293.45, the stock P/E ratio is at 21.48 x F Y18E and 18.06 X F Y19E respectively. Net Sales and PAT of the company are expected to grow at a CAGR of 26% and 55% ove...
Firstcall India Equity, 21 Feb 2018
Minda Industries Q3FY18: Strong play on premiumization of cars; retain ADD
MNDA delivered yet another strong quarter driven by strong growth in alloy wheels, standalone lighting, horns and batteries. We believe MNDA is an excellent long-term play on premiumization
Equirus Securities, 20 Feb 2018
Finolex Industries Q3FY18: Solid volume growth; maintain ADD
Finolex Industries (FNXP) reported a 13% yoy decline in its 3QFY18 EBITDA to Rs 1.13bn due to normalization of PVC spreads and margin pressure in the pipes segment. A key highlight was the robust 50% ...
Equirus Securities, 20 Feb 2018
PNC Infratech Q3FY18: Operational performance hit by AD delays, revival to be slow; maintain Reduce
PNC Infratech’s (PNCL) 3QFY18 revenues were impacted by delays in receiving AD for projects owing to land acquisition issues. Our thesis of FY18E execution being hit due to slow-moving projects has pl...
Equirus Securities, 20 Feb 2018
Sadbhav Engineering Q3: Attractively valued at the brink of an industry level order explosion; maintain Long
Sadbhav Engineering reported moderate execution growth along with margin outperformance in 3QFY18, which led to an in-line PBT performance. Margin expansion was supported by higher-margin HAM projects...
Equirus Securities, 20 Feb 2018
JK Paper Q3 Results: Strong set of numbers posted; Buy
Company has posted strong set of numbers in Q3FY18 with bottomline of company surging by almost more than 90% at Rs 69.81 Cr against Rs 35.89 Cr in Q3FY17. The rise was on account of increase in volum...
Hem Securities, 20 Feb 2018
Sun Pharmaceuticals Q3 Results: Underlying business resilient; upgrade to ADD
Sun Pharma’s (SUNP) 3QFY18 sales declined 16% yoy to Rs 66.5bn, 6% below EE largely owing to lower growth in domestic and emerging markets. EBITDA/PAT came in 5%/62% below EE.
Equirus Securities, 20 Feb 2018
View All

Intraday Tips

What are technical calls?
* SEBI certified analyst

View Stock Advice by: